Page last updated: 2024-11-05

trifluoperazine and Menopause

trifluoperazine has been researched along with Menopause in 4 studies

Menopause: The last menstrual period. Permanent cessation of menses (MENSTRUATION) is usually defined after 6 to 12 months of AMENORRHEA in a woman over 45 years of age. In the United States, menopause generally occurs in women between 48 and 55 years of age.

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19904 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
LITKEWITSCH, H1
MAZZA, PA1
Dudley, B1
Zeitner, RM1
Frank, MV1
Freeman, SM1

Other Studies

4 other studies available for trifluoperazine and Menopause

ArticleYear
ANTIDEPRESSANT-TRANQUILIZER REGIMEN IN MENOPAUSAL PATIENTS.
    Journal of the American Medical Women's Association, 1963, Volume: 18

    Topics: Antidepressive Agents; Female; Humans; Hypnotics and Sedatives; Menopause; Tranquilizing Agents; Tra

1963
Tranylcypromine and trifluoperazine in the management of the menopausal syndrome.
    Diseases of the nervous system, 1962, Volume: 23

    Topics: Anxiety; Anxiety Disorders; Depression; Depressive Disorder; Menopause; Monoamine Oxidase Inhibitors

1962
Treatment of the artificial menopause.
    The Practitioner, 1967, Volume: 198, Issue:187

    Topics: Barbiturates; Breast Neoplasms; Carcinoma; Castration; Female; Humans; Mastectomy; Menopause; Middle

1967
Pharmacogenic and psychogenic aspects of galactorrhea: case report.
    The American journal of psychiatry, 1980, Volume: 137, Issue:1

    Topics: Adolescent; Adult; Antipsychotic Agents; Female; Galactorrhea; Humans; Lactation Disorders; Menopaus

1980